Dose: A critical factor in cancer chemotherapy
- 1 October 1980
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 69 (4), 585-594
- https://doi.org/10.1016/0002-9343(80)90472-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Dose response evaluation of adriamycin in human neoplasiaCancer, 1977
- A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary reportCancer, 1977
- HOW STRONG IS THE CASE FOR INTENSIVE CANCER CHEMOTHERAPY?The Lancet, 1976
- Characteristics of prognosis and response to an imidazole carboxamide in malignant melanomaClinical Pharmacology & Therapeutics, 1971
- Drug dosage and remission duration in childhood lymphocytic leukemiaCancer, 1971
- 5-Fluorouracil in Cancer: An Improved RegimenAnnals of Internal Medicine, 1970
- Is toxicity really necessary? I. The questionCancer, 1966
- Clinical studies of dichloromethotrexate (NSC 29630)Clinical Pharmacology & Therapeutics, 1965
- Further comparative trial of triethylene thiophosphoramide and mechlorethamine in patients with Melanoma and Hodgkin's diseaseJournal of Chronic Diseases, 1964
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and MethotrexateBlood, 1961